€ 3.5 million

GENESIS Biomed and especially its CEO and founder, Josep Lluís Falcó, have supported Anaconda Biomed since the before the start-up was founded. The advice received from GENESIS has been very valuable in helping our company achieve its goals. This collaboration is still on going and we are very pleased with everything they have contributed to our project.

<b>Ofir Arad</b><br /><em>CEO Anaconda Biomed</em> - http://anaconda.bio/

Weekly contact, hard-work, proximity, fast response and professionalism define our relationship with GENESIS. They are one more member of our team, creating a real, structured pathway. Together, we raised an initial investment, thanks to their friendly, personalised advice.

<b>Adrià Maceira</b><br /><em>CEO CreatSens Health</em> - http://creatsens.com/

MJN Neuroserveis has developed a medical device to record and assess the risk of an epileptic crisis. The project began as the personal venture of one of the co-founders, as he has a daughter affected by this disease. Thanks to the help of GENESIS Biomed, at MJN we have been able to understand the clinical, regulatory, financing, commercial planning and other steps that need to be taken so we can undertake a project of this kind, not merely at the planning level. GENESIS Biomed is currently helping us to execute all these plans to make the MJN project happen.

<b>Salvador Gutiérrez</b><br /><em>CEO MJN Neuroserveis</em> - http://mjn.cat/

I just wanted to share a few lines on the great job you are doing. As far as we've seen, all the companies you work with are boosted by the advice you give them. Specifically, GENESIS is providing us with due diligence advice on the biotechnology sector, which helps us in searching companies to invest in. Thanks for your help.

<b>Marc Botet</b><br /><em>CEO Jormavi S.L.</em>

We have begun a fruitful relationship with GENESIS Biomed. As a TTO we can leverage GENESIS wide expertise in developing life science projects. From a regulatory affairs point of view, GENESIS provides us a vantage point to prioritise our next steps by designing an optimised roadmap for the development of the project together. In terms of investment, GENESIS Ventures has contributed to moving a project forward in the value chain, so we can cross with the Valley of Death with fewer uncertainties.

<b>Lucas Martín</b><br /><em>Technology Transfer Manager UAB</em> - http://www.uab.cat/

The collaboration with GENESIS Biomed started last year and it was profitable for both organisations. GENESIS has helped us to draw up the EIT Health Spain strategic plan 2017-2020 and EIT Health has the doors of an international network of excellence to the company. This collaboration is a good example of how to integrate local ecosystem key players and strong partners who are leaders in European innovation.

<b>Marco Pugliese</b><br /><em>CEO EIT Health Spain</em> - https://www.eithealth.eu/

It is always a great pleasure to work with GENESIS! The professionalism and dedication of the members of this company is reflected in great success when evaluating the results of their work. Our current joint project: HOOP, a wearable ambulatory service for Parkinson's patients, has been chosen to begin a new business venture as part of ACTUA UPM thanks to its support. I wish GENESIS and its members great success!

<b>María Teresa Arredondo</b><br /><em>Director of LifeSTech. Director of Vodafone Chair at UPM</em> - http://www.upm.es/

We consider ourselves fortunate to be able to draw on the advice and facilities of GENESIS Biomed in our everyday work. Its experience, networking, cordiality and, above all, honesty and commitment to our company, have made it possible for the CORNEA Project to move forward more solidly, safely and effectively. As CEO of CORNEA, I cannot contemplate moving forward without the inestimable help of GENESIS Biomed.

<b>Pere del Campo</b><br /><em>CEO CORNEA Project</em> - http://www.corneaproject.com/

We have been working with GENESIS Biomed from the very beginning and Josep Lluís Falcó was a key collaborator in raising our first funding round. Far from being just a consulting company, GENESIS Biomed’s involvement in our project has made them a member of GlyCardial’s team.

<b>Judit Cubedo</b><br /><em>CEO GlyCardial Diagnostics</em> - http://www.glycardial.com/

GENESIS Biomed was a key figure in the foundation of Leukos Biotech, but, more importantly, they have supported and advised us as we have grown and evolved, adapting their services to our changing needs. After two years working together, GENESIS Biomed has become an indispensable source of assistance, guidance and encouragement.

<b>Erique Llaudet</b><br /><em>CEO Leukos Biotech</em> - http://www.leukosbiotech.com/

Josep Lluís has been working with us since the very beginning of AptaTargets. The aim was for him to help us with an initial roadmap for the company development, from the early preclinical stage (where we then were) to clinical stages and the market. Mutually positive- feelings convinced us to continue working with Josep Lluís in one of the critical steps for a start-up, which is closing an investment round. This was a very challenging step, as AptaTargets was based on an almost unknown technology (aptamers) and a scary first indication (stroke). Josep Lluís played an important role, supporting us in different technical disciplines, such as regulations and CMC (chemicals, manufacturing & controls), as well as in business-related activities. He had been through this process before many times and his experience was valuable. We also enjoyed his human support in helping us to overcome difficulties, and this is also very valuable!.

<b>David Segarra</b> <br /><em>CEO AptaTargets</em> - http://www.aptatargets.com/

As Executive Director of Peptomyc, I would like to thank Genesis Biomed and its founder and director Dr Josep Lluís Falcó for their continuous professional support over the last few years. The Genesis team includes highly qualified health professionals who have been working with us since the very beginning of Peptomyc in the business world. His enthusiasm for our project has been continuous and very helpful. Genesis’s consultancy has supported us in preparing a business plan, strategic consulting, a market study and the preparation of a regulatory development plan, as well as the search for public and private funds. Our particular gratitude goes to Dr Falcó, for having worked hard, suffered and celebrated with us at every step of our project as an integral part of our team.

<b>Laura Soucek</b> <br /><em>CEO Peptomyc</em> - http://www.peptomyc.com/